Priority Date: 03.07.12 (EP 20120174781)

OLIGONUCLEOTIDE FOR THE TREATMENT OF MUSCULAR DYSTROPHY PATIENTS

  • Application ID: EP13739847
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna nlo
operating since 1888
Headquarter in The Hague and 3 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 129 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 03.07.2012 - Priority Date (EP 20120174781)
  • 09.01.2014 - Publication A2 (WO2014007620)
  • 13.05.2015 - Publication A2 (EP2870246)